Cullinan Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	78.64	88.33	83.01	98.43	156.15	59.77
Short-Term Investments	255.9	289.56	315.97	368.63	311.14	230.69
Cash & Short-Term Investments	334.54	377.9	398.98	467.07	467.29	290.47
Cash Growth	26.01%	-5.28%	-14.58%	-0.05%	60.88%	38.18%
Other Receivables	2.38	2.83	3	-	-	-
Receivables	2.38	2.83	3	-	-	-
Prepaid Expenses	5.06	6.03	12.69	13.12	7.18	6.1
Total Current Assets	341.97	386.76	414.67	480.19	474.47	296.56
Property, Plant & Equipment	2.5	3.05	2.35	3.53	5.3	0.08
Long-Term Investments	19.02	58.27	204.44	-	80.88	140.4
Other Long-Term Assets	0.3	0.3	0.37	0.46	0.46	0.15
Total Assets	363.79	448.37	621.82	484.18	561.12	437.19
Accounts Payable	3.73	0.84	1.68	2.49	2.66	3.17
Accrued Expenses	34.71	35.12	26.23	23.29	12	7.6
Short-Term Debt	-	-	-	-	0.18	-
Current Portion of Leases	0.67	0.78	1.3	1.44	1.42	-
Current Income Taxes Payable	-	-	-	-	4.28	-
Other Current Liabilities	1.53	1	1.44	0.91	1.96	0.97
Total Current Liabilities	40.63	37.74	30.65	28.14	22.5	11.75
Long-Term Leases	1.41	1.9	0.85	2.15	3.59	-
Other Long-Term Liabilities	-	-	-	-	-	0.07
Total Liabilities	42.03	39.64	31.5	30.29	26.09	11.81
Common Stock	0.01	0.01	0.01	0	0.01	0
Additional Paid-In Capital	1,013	995.82	958.7	654.69	585.32	584.71
Retained Earnings	-691.48	-588.12	-368.24	-200.86	-47.7	-158.91
Comprehensive Income & Other	-0.13	1.02	-0.13	-0.13	-2.6	-0.84
Total Common Equity	321.75	408.73	590.33	453.7	535.03	424.97
Minority Interest	-	-	-	0.19	-	0.4
Shareholders' Equity	321.75	408.73	590.33	453.9	535.03	425.37
Total Liabilities & Equity	363.79	448.37	621.82	484.18	561.12	437.19
Total Debt	2.07	2.68	2.15	3.59	5.19	-
Net Cash (Debt)	332.47	375.21	396.83	463.48	462.1	290.47
Net Cash Growth	25.95%	-5.45%	-14.38%	0.30%	59.09%	38.18%
Net Cash Per Share	5.54	6.35	7.38	11.15	9.91	6.74
Filing Date Shares Outstanding	64.35	60.53	58.51	43.07	39.33	44.61
Total Common Shares Outstanding	64.35	60.24	58.51	42.9	45.8	44.29
Working Capital	301.35	349.02	384.02	452.05	451.97	284.82
Book Value Per Share	5.00	6.78	10.09	10.58	11.68	9.59
Tangible Book Value	321.75	408.73	590.33	453.7	535.03	424.97
Tangible Book Value Per Share	5.00	6.78	10.09	10.58	11.68	9.59
Machinery	-	0.81	0.77	0.77	0.68	0.2
Leasehold Improvements	-	0.58	0.58	0.58	0.63	0.11

SEC Filings: 10-K · 10-Q